Leonard Pinchuk, Ph.D., D.Sc. (h.c.), NAE, Founder, InnFocus, Inc., a Santen Company, and Distinguished Research Professor, Biomedical Engineering, University of Miami, Miami FL Dr. Pinchuk is an inventor and entrepreneur with 127 U.S. patents, 90 publications and 10 companies that he co-founded. His major accomplishments include the invention of the modern-day angioplasty balloon, the helical wire stent, the modular stent-graft, a drug-eluting stent (TAXUS®), several biomaterials, a novel glaucoma shunt and the next generation intraocular lens. He was the recipient of the 2017 Society for Biomaterials Innovation and Technology Award as well as San Antonio’s BIOMED SA Award. He received a B.Sc. in chemistry from McGill University (1976), a Ph.D. interdisciplinary in Engineering and Chemistry from the University of Miami (1984) and an honorary Doctor of Science degree from McGill University (2005). He was inducted into AIMBE in 2007 and the National Academy of Engineering in 2012. Dr. Pinchuk left Cordis Corporation in 1987 to co-found Corvita Corporation (angioplasty catheters, stents, stent-grafts), which went public in 1994, was acquired by Pfizer, Inc. (1996) and then sold to Boston Scientific (1998). He then founded Innovia LLC (2002), which incubated many companies working in the fields of intraocular lenses, glaucoma shunts, radiation oncology, urology, gene therapy and others. His current company, InnFocus, Inc., (glaucoma device) was acquired by Santen Corporation in May 2016, where he spends most of his time serving as CSO. Dr. Pinchuk also enjoys an appointment as Distinguished Research Professor of Biomedical Engineering at the University of Miami.